Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    Ustekinumab crohn's phase 3 | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease
Condition: Crohn Disease
Interventions: Drug: JNJ-64304500;   Drug: Placebo;   Drug: Ustekinumab

Indicates status has not been verified in more than two years